www.wsj.com
Open in
urlscan Pro
2600:9000:2156:e000:3:4b0:de80:93a1
Public Scan
URL:
https://www.wsj.com/articles/ivermectin-didnt-reduce-covid-19-hospitalizations-in-largest-trial-to-date-11647601200
Submission: On March 18 via manual from IE — Scanned from DE
Submission: On March 18 via manual from IE — Scanned from DE
Form analysis
1 forms found in the DOM#
<form action="#" class="style--search-form-hI0pb2JfplZrewKUN--51 " role="search"><input id="searchInput" class="style--wsj-search-input-GNMy8Q5kg9IYwJKXYfIMm " placeholder="Enter News, Quotes, Companies or Videos" type="search"
aria-label="Search the Wall Street Journal" tabindex="-1"><button class="style--search-submit-2EFgMYmHzRT8YBR7BYrV6G " aria-label="Submit Button" value="Search" type="submit" tabindex="-1">Search <svg width="24" height="24" viewBox="0 0 24 24">
<defs>
<path id="search-medium_svg__a" d="M10.5 2a7.5 7.5 0 015.645 12.438l5.365 5.365-.707.707-5.365-5.365A7.5 7.5 0 1110.5 2zm0 1a6.5 6.5 0 100 13 6.5 6.5 0 000-13z"></path>
</defs>
<use fill="currentColor" fill-rule="evenodd" xlink:href="#search-medium_svg__a"></use>
</svg></button></form>
Text Content
Skip to Main ContentSkip to SearchSkip to... Select * Listen to Article * What To Read Next * Opinion Editor's Picks * Sponsored Offers * Most Popular Articles * Most Popular Opinion * Opinion Editor's Picks * Recommended Videos Dow Jones, a News Corp companyAbout WSJ * News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. * Dow Jones * Barron's * BigCharts * Dow Jones Businesses * Dow Jones Newswires * Factiva * Financial News * Mansion Global * MarketWatch * Newsmart * NewsPlus * Risk & Compliance * WSJ Live * WSJ Pro * WSJ Video * WSJ.com * News Corp * Avail * Business Spectator * HarperCollins Publishers * Housing * Makaan * New York Post * REA * realtor.com * Storyful * The Australian * The Sun * The Times * DJIA34460.50 points with a0.06%▼ S&P 5004427.81 points with a0.37%▲ Nasdaq13785.14 points with a1.25%▲ U.S. 10 Yr3/32 Yieldwith a2.151%▲ Crude Oil104.57 points with a1.54%▲ Euro1.1060 points with a0.30%▼ The Wall Street Journal SubscribeSign In Special Offer The Wall Street Journal Less than US $1/week Get the insights and analysis trusted by key decision-makers around the world. Become a WSJ Member Today View Membership Options English Edition * English * 中文 (Chinese) * 日本語 (Japanese) Print Edition Video Podcasts Latest Headlines SubscribeSign In * Home * World REGIONS * Africa * Asia * Canada * China * Europe * Latin America * Middle East SECTIONS * Economy MORE * World Video * U.S. SECTIONS * Economy * Law * Politics MORE * WSJ Noted. * U.S. Video * What's News Podcast * Politics SECTIONS * Capital Journal MORE * Politics Video COLUMNS * Gerald Seib * Washington Wire * Economy WSJ PRO * Bankruptcy * Central Banking * Private Equity * Strategic Intelligence * Venture Capital MORE * Economic Forecasting Survey * Economy Video SECTIONS * Capital Account * Business SECTIONS * Management * The Future of Everything * Obituaries * Tech/WSJ.D INDUSTRIES * Aerospace & Defense * Autos & Transportation * Commercial Real Estate * Consumer Products * Energy * Entrepreneurship * Financial Services * Food & Services * Health Care * Hospitality * Law * Manufacturing * Media & Marketing * Natural Resources * Retail C-SUITE * CFO Journal * CIO Journal * CMO Today * Logistics Report * Risk & Compliance * The Workplace Report COLUMNS * Heard on the Street WSJ PRO * Bankruptcy * Central Banking * Cybersecurity * Private Equity * Sustainable Business * Venture Capital MORE * Business Video * Journal Report * Business Podcast * Space & Science * Tech SECTIONS * CIO Journal * The Future of Everything * Personal Tech COLUMNS * Christopher Mims * Joanna Stern * Julie Jargon * Nicole Nguyen MORE * Tech Video * Tech Podcast * Markets SECTIONS * Bonds * Commercial Real Estate * Commodities & Futures * Stocks * Personal Finance * WSJ Money * Streetwise * Intelligent Investor COLUMNS * Heard on the Street * Greg Ip * Jason Zweig * Laura Saunders * James Mackintosh MARKET DATA * Market Data Home * U.S. Stocks * Currencies * Companies * Commodities * Bonds & Rates * Mutual Funds & ETFs MORE * CFO Journal * Markets Video * Your Money Briefing Podcast * Secrets of Wealthy Women Podcast Search Quotes and Companies * Opinion COLUMNISTS * Gerard Baker * Sadanand Dhume * James Freeman * William A. Galston * Daniel Henninger * Holman W. Jenkins * Andy Kessler * William McGurn * Walter Russell Mead * Peggy Noonan * Mary Anastasia O'Grady * Jason Riley * Joseph Sternberg * Kimberley A. Strassel MORE * Editorials * Commentary * Future View * Letters to the Editor * The Weekend Interview * Potomac Watch Podcast * Foreign Edition Podcast * Free Expression Podcast * Opinion Video * Notable & Quotable * Books & Arts REVIEWS * Film * Television * Theater * Masterpiece Series * Music * Dance * Opera * Exhibition * Cultural Commentary SECTIONS * Arts * Books MORE * WSJ Puzzles * Life Video * Arts Video * Real Estate SECTIONS * Commercial Real Estate MORE * Real Estate Video * Life & Work SECTIONS * Cars * Careers * Entertainment * Food & Drink * Home & Design * Ideas * Personal Finance * Recipes * Style & Fashion * Travel * Wellness COLUMNS * Your Health * Work & Life * The Middle Seat * Bonds * At Work * Turning Points * Off Brand * On Trend * On Wine MORE * WSJ Puzzles * Space & Science * WSJ. Magazine SECTIONS * Fashion * Art & Design * Travel * Food * Culture * Sports SECTIONS * Beijing 2022 Olympics * MLB * NBA * NFL * Golf * Tennis * Soccer COLUMNS * Jason Gay Search * Home * World REGIONS * Africa * Asia * Canada * China * Europe * Latin America * Middle East SECTIONS * Economy MORE * World Video * U.S. SECTIONS * Economy * Law * Politics MORE * WSJ Noted. * U.S. Video * What's News Podcast * Politics SECTIONS * Capital Journal MORE * Politics Video COLUMNS * Gerald Seib * Washington Wire * Economy WSJ PRO * Bankruptcy * Central Banking * Private Equity * Strategic Intelligence * Venture Capital MORE * Economic Forecasting Survey * Economy Video SECTIONS * Capital Account * Business SECTIONS * Management * The Future of Everything * Obituaries * Tech/WSJ.D INDUSTRIES * Aerospace & Defense * Autos & Transportation * Commercial Real Estate * Consumer Products * Energy * Entrepreneurship * Financial Services * Food & Services * Health Care * Hospitality * Law * Manufacturing * Media & Marketing * Natural Resources * Retail C-SUITE * CFO Journal * CIO Journal * CMO Today * Logistics Report * Risk & Compliance * The Workplace Report COLUMNS * Heard on the Street WSJ PRO * Bankruptcy * Central Banking * Cybersecurity * Private Equity * Sustainable Business * Venture Capital MORE * Business Video * Journal Report * Business Podcast * Space & Science * Tech SECTIONS * CIO Journal * The Future of Everything * Personal Tech COLUMNS * Christopher Mims * Joanna Stern * Julie Jargon * Nicole Nguyen MORE * Tech Video * Tech Podcast * Markets SECTIONS * Bonds * Commercial Real Estate * Commodities & Futures * Stocks * Personal Finance * WSJ Money * Streetwise * Intelligent Investor COLUMNS * Heard on the Street * Greg Ip * Jason Zweig * Laura Saunders * James Mackintosh MARKET DATA * Market Data Home * U.S. Stocks * Currencies * Companies * Commodities * Bonds & Rates * Mutual Funds & ETFs MORE * CFO Journal * Markets Video * Your Money Briefing Podcast * Secrets of Wealthy Women Podcast Search Quotes and Companies * Opinion COLUMNISTS * Gerard Baker * Sadanand Dhume * James Freeman * William A. Galston * Daniel Henninger * Holman W. Jenkins * Andy Kessler * William McGurn * Walter Russell Mead * Peggy Noonan * Mary Anastasia O'Grady * Jason Riley * Joseph Sternberg * Kimberley A. Strassel MORE * Editorials * Commentary * Future View * Letters to the Editor * The Weekend Interview * Potomac Watch Podcast * Foreign Edition Podcast * Free Expression Podcast * Opinion Video * Notable & Quotable * Books & Arts REVIEWS * Film * Television * Theater * Masterpiece Series * Music * Dance * Opera * Exhibition * Cultural Commentary SECTIONS * Arts * Books MORE * WSJ Puzzles * Life Video * Arts Video * Real Estate SECTIONS * Commercial Real Estate MORE * Real Estate Video * Life & Work SECTIONS * Cars * Careers * Entertainment * Food & Drink * Home & Design * Ideas * Personal Finance * Recipes * Style & Fashion * Travel * Wellness COLUMNS * Your Health * Work & Life * The Middle Seat * Bonds * At Work * Turning Points * Off Brand * On Trend * On Wine MORE * WSJ Puzzles * Space & Science * WSJ. Magazine SECTIONS * Fashion * Art & Design * Travel * Food * Culture * Sports SECTIONS * Beijing 2022 Olympics * MLB * NBA * NFL * Golf * Tennis * Soccer COLUMNS * Jason Gay Search Search COVID-19 Covid TrackerBA.2 VariantTreating Covid-19Booster Q&AVaccinating ChildrenMask Q&AInsurance and At-Home Tests Share * Facebook * Twitter * LinkedIn * Copy Link * WSJ News Exclusive * Health IVERMECTIN DIDN’T REDUCE COVID-19 HOSPITALIZATIONS IN LARGEST TRIAL TO DATE PATIENTS WHO GOT THE ANTIPARASITIC DRUG DIDN’T FARE BETTER THAN THOSE WHO RECEIVED A PLACEBO Should We Get a Second Booster Vaccine? What the Science Says Skip Ad in 15 You may also like CloseCreated with sketchtool. Up Next CloseCreated with sketchtool. Your browser does not support HTML5 video. 0:00 PlayCreated with sketchtool. Paused Sound OnCreated with sketchtool. 0:00 / 6:04 ShareCreated with sketchtool.Closed Captions InactiveCreated with sketchtool. Should We Get a Second Booster Vaccine? What the Science SaysPlay video: Should We Get a Second Booster Vaccine? What the Science Says Amid a surge in cases, some countries are handing out second booster shots. In Israel, early data suggest a fourth vaccine dose can increase antibodies against Covid-19, but not enough to prevent infections from Omicron. WSJ explains. Photo composite: Eve Hartley/WSJ By Sarah Toy Updated March 18, 2022 10:16 am ET Print Text 567 Researchers testing repurposed drugs against Covid-19 found that ivermectin didn’t reduce hospital admissions, in the largest trial yet of the effect of the antiparasitic on the disease driving the pandemic. To Read the Full Story Subscribe Sign In CONTINUE READING YOUR ARTICLE WITH A WSJ MEMBERSHIP SPECIAL OFFER LESS THAN US $1/WEEK View Membership Options RESUME SUBSCRIPTION We are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service. Please click confirm to resume now. Confirm Sponsored Offers * Wayfair: Extra 15% off + free shipping at Wayfair * Target: Up to 60% off - Target Promo Code * Macy's: Macy's coupon - Sign up to get 25% off next order * Kohl's: Kohl's coupon - 30% off for Rewards members * Saks Fifth Avenue: $20 off sitewide + free shipping - Saks Fifth Avenue coupon * PrettyLittleThing: Sign up for emails and get 20% off PrettyLittleThing discount code + $1 shipping MOST POPULAR NEWS * HOW RUSSIA’S REVAMPED MILITARY FUMBLED THE INVASION OF UKRAINE * UKRAINE HAS BECOME A GRAVEYARD FOR RUSSIAN TANKS * A UKRAINIAN TOWN DEALS RUSSIA ONE OF THE WAR’S MOST DECISIVE ROUTS * DESPERATION MOUNTS FOR UKRAINIANS IN MARIUPOL AS RUSSIA TRIES TO CAPTURE KEY CITY * PUTIN ACKNOWLEDGES IMPACT OF SANCTIONS ON RUSSIAN ECONOMY MOST POPULAR OPINION * OPINION: CHINA’S GREAT-POWER PLAY * OPINION: BIDEN IS IN CLIMATE DENIAL * OPINION: TURKEY’S RUSSIAN MISSILES COULD DEFEND UKRAINE * OPINION: ON UKRAINE, HISTORY IS LISTENING * OPINION: GERMANY TO RUSSIA: WE’RE BUYING THE F-35 RECOMMENDED VIDEOS * CONTAINER SHIP RUNS AGROUND IN THE CHESAPEAKE BAY * HOW THE FEDERAL RESERVE RAISES INTEREST RATES * ZELENSKY ASKS CONGRESS FOR NO-FLY ZONE, INCREASED RUSSIAN SANCTIONS * HOW RUSSIA’S NUCLEAR ARSENAL, THE WORLD’S LARGEST, COMPARES WITH OTHERS * NFTS AND PLAY-TO-EARN GAMES SHED LIGHT ON FUTURE OF METAVERSE ECONOMY * The Wall Street Journal * English Edition * English * 中文 (Chinese) * 日本語 (Japanese) * * Subscribe Now * Sign In * Back to Top « WSJ Membership * WSJ+ Membership Benefits * Subscription Options * Why Subscribe? * Corporate Subscriptions * Professor Journal * Student Journal * WSJ High School Program * Public Library Program * WSJ Live Customer Service * Customer Center * Contact Us Tools & Features * Newsletters & Alerts * Guides * Topics * My News * RSS Feeds * Video Center * Watchlist * Podcasts * Visual Stories Ads * Advertise * Commercial Real Estate Ads * Place a Classified Ad * Sell Your Business * Sell Your Home * Recruitment & Career Ads * Coupons * Digital Self Service More * About Us * Commercial Partnerships * Content Partnerships * Corrections * Jobs at WSJ * News Archive * Register for Free * Reprints & Licensing * Buy Issues * WSJ Shop * Facebook * Twitter * Instagram * YouTube * Podcasts * Snapchat * Google Play * App Store Dow Jones Products * Barron's * BigCharts * Dow Jones Newswires * Factiva * Financial News * Mansion Global * MarketWatch * Risk & Compliance * WSJ Pro * WSJ Video * WSJ Wine * Privacy Notice * Cookie Notice * Copyright Policy * Data Policy * Subscriber Agreement & Terms of Use * Your Ad Choices * Accessibility * Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved.